Experts Recommend Hormone Replacement Therapy as Primary Treatment for Menopause Symptoms

If you're experiencing menopause symptoms, hormone replacement therapy, or HRT, is now being advised as the primary treatment to consider, instead of other therapies. Experts at the National Institute for Health and Care Excellence, known as NICE, have recently updated their guidance for women in England and Wales to reflect this approach.

Symptoms like mood swings, trouble sleeping, and hot flushes can really disrupt your daily life during menopause. HRT works by supplementing your body with estrogen and progesterone, hormones that naturally decrease during menopause. This helps to restore balance and relieve many of these challenging symptoms. Before starting HRT, your GP will have a detailed and personalised discussion with you to tailor treatment to your individual needs and health background.

Previously, there was guidance suggesting that cognitive behavioural therapy (CBT) could be used alongside or even as an alternative to HRT for managing menopause symptoms. However, that advice received criticism from many who felt it downplayed the severity of symptoms by equating a psychological approach with hormone treatment.

Following extensive consultations with healthcare professionals, research groups, and patients, NICE has revised this stance. They now emphasize HRT as the preferred initial treatment, reserving CBT for those who either continue to experience symptoms despite hormone therapy or choose not to take HRT for personal reasons.

Prof Jonathan Benger, chief medical officer and acting director at NICE's centre for guidelines, clarified that CBT should not be seen as interchangeable with HRT. He stressed, 'It's not a matter of choosing one over the other; rather, HRT remains the primary treatment for menopausal symptoms like hot flushes and mood changes. CBT may play a supportive role but only in specific situations.'

Alongside updates in the guidelines, NICE has developed a handy 'discussion aid' designed for use during consultations between women and their doctors. This tool provides clear information about how HRT might increase the risk of some health issues, including breast cancer and blood clots, while also offering protective benefits like lowering the chance of osteoporosis.

Importantly, recent reviews reinforce that when HRT is started around the typical menopausal age range—between 45 and 55—there appears to be no associated increase in risks for heart disease, stroke, or dementia. This is reassuring news for many women seeking treatment options.

The decision to use HRT involves weighing these benefits and risks carefully with your healthcare provider. With the right information, you can make a fully informed choice that suits your lifestyle and health priorities.

If menopause symptoms like hot flushes, mood swings, or sleep difficulties are impacting your day-to-day life, don’t hesitate to reach out to your doctor for advice on HRT. You can obtain hormone replacement therapy through NHS prescriptions, with a single item currently costing £9.90.

For those who find themselves needing HRT medication regularly, it's worth considering an HRT prescription payment certificate (HRT PPC), which costs £19.80 for a 12-month period. This certificate means you won't have to pay for each prescription separately and can cover the entire range of your HRT medications throughout the year.

Estrogen in HRT is available in various forms such as skin patches, gels or sprays applied to the skin, implants placed under the skin, or oral tablets. Progesterone options include patches combined with estrogen, intrauterine systems (IUS, commonly known as coils), or tablets. Your GP will help decide which form fits best with your needs and preferences.

Having open conversations with your healthcare provider about your symptoms, concerns, and treatment options is essential. That way, you can navigate menopause with support tailored specifically for you, easing symptoms and improving your overall quality of life.

Some voices in the community have expressed disappointment with the new guidance, feeling it risks stepping backward in menopause care. For example, a Labour MP who previously worked on women's and equality issues shared concerns that the guidelines may not truly listen to women’s experiences or provide clear, accessible pathways for treatment.

Similarly, leaders in women’s online support networks have voiced worry that the emphasis on CBT, which remains limited in availability, could leave many women struggling without timely access to effective HRT treatments. They highlight the urgent need for healthcare systems to equip both women and doctors with thorough, easy-to-understand information to make informed decisions about menopause care.

These reactions underscore the continuing conversation around the best ways to support women through menopause. It’s clear that while guidelines provide a framework, ongoing dialogue between patients and healthcare professionals is critical to ensure everyone gets the personalized care they deserve.

By staying informed and advocating for your health needs, you can play an active role in your menopause journey. It’s important to remember you’re not alone—there are many resources and communities ready to support you through these changes.